All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY993 | Anti-AP1G1 (100/3) h(41BB-CD3ζ) CAR, pCDCAR1 | Cattle | 100/3 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY994 | Anti-AP1G1 (CBLG1-3123) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat | CBLG1-3123 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY995 | Anti-AP1G1 (CBLG1-3124) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat | CBLG1-3124 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY996 | Anti-AP1G1 (CBLG1-2472) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-2472 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY997 | Anti-AP1G1 (CBLG1-3125) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3125 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2633 | Anti-AP1G1(100/3) h(CD28-CD3ζ) CAR, pCDCAR1 | Cattle | 100/3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2634 | Anti-AP1G1(CBLG1-3123) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat | CBLG1-3123 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2635 | Anti-AP1G1(CBLG1-3124) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat | CBLG1-3124 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2636 | Anti-AP1G1(CBLG1-2472) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-2472 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2637 | Anti-AP1G1(CBLG1-3125) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3125 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION